WITH reference to the article, 'Pharmacy Cannabis Training', which appeared in Pharmacy Daily on February 6, 2018, MedReleaf Australia wishes to retract the statement that 'a comprehensive medicinal cannabis education program under development by NPS MedicineWise subsidiary VentureWise had an aim of "building confidence in MedReleaf's formulations"'.
MedReleaf Australia wishes to acknowledge the staunchly independent nature of NPS MedicineWise and the highly valuable contribution that its educational programs make to health professionals.
The above article was sent to subscribers in Pharmacy Daily's issue from 12 Feb 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Feb 18
